These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
297 related articles for article (PubMed ID: 12162916)
1. CHOP and rituximab in elderly patients. Portlock CS Curr Oncol Rep; 2002 Sep; 4(5):414. PubMed ID: 12162916 [No Abstract] [Full Text] [Related]
2. Rituximab plus CHOP for diffuse large-B-cell lymphoma. Akhtar S; Maghfoor I N Engl J Med; 2002 Jun; 346(23):1830-1; author reply 1830-1. PubMed ID: 12050349 [No Abstract] [Full Text] [Related]
3. [Comparison of rituximab plus CHOP regimen and CHOP regimen alone for treatment of newly diagnosed patients with diffuse large B-cell lymphoma]. Wu HJ; Zhang QY; Chen DF; Guan XJ; Zhang BL; Ma J Ai Zheng; 2005 Dec; 24(12):1498-502. PubMed ID: 16351800 [TBL] [Abstract][Full Text] [Related]
4. Cost utility in the United States of rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone for the treatment of elderly patients with diffuse large B-cell lymphoma. Hornberger JC; Best JH Cancer; 2005 Apr; 103(8):1644-51. PubMed ID: 15756658 [TBL] [Abstract][Full Text] [Related]
5. Rituximab-CHOP versus CHOP alone or with maintenance rituximab in older patients with diffuse large B-cell lymphoma. Habermann TM; Weller EA; Morrison VA; Gascoyne RD; Cassileth PA; Cohn JB; Dakhil SR; Woda B; Fisher RI; Peterson BA; Horning SJ J Clin Oncol; 2006 Jul; 24(19):3121-7. PubMed ID: 16754935 [TBL] [Abstract][Full Text] [Related]
6. Introduction of combined CHOP plus rituximab therapy dramatically improved outcome of diffuse large B-cell lymphoma in British Columbia. Sehn LH; Donaldson J; Chhanabhai M; Fitzgerald C; Gill K; Klasa R; MacPherson N; O'Reilly S; Spinelli JJ; Sutherland J; Wilson KS; Gascoyne RD; Connors JM J Clin Oncol; 2005 Aug; 23(22):5027-33. PubMed ID: 15955905 [TBL] [Abstract][Full Text] [Related]
7. FcgammaRIIB expression in diffuse large B-cell lymphomas does not alter the response to CHOP+rituximab (R-CHOP). Camilleri-Broët S; Mounier N; Delmer A; Brière J; Casasnovas O; Cassard L; Gaulard P; Christian B; Coiffier B; Sautès-Fridman C Leukemia; 2004 Dec; 18(12):2038-40. PubMed ID: 15470484 [No Abstract] [Full Text] [Related]
8. Persistent panhypogammaglobulinemia after CHOP-rituximab for HIV-related lymphoma. Miles SA; McGratten M J Clin Oncol; 2005 Jan; 23(1):247-8. PubMed ID: 15625386 [No Abstract] [Full Text] [Related]
9. [Comparison between R-CHOP regimen and CHOP regimen in treating naive diffuse large B-cell lymphoma in China--a multi-center randomized trail]. Lin TY; Zhang HY; Huang Y; Guan ZZ; Shen T; Shi YK; Zhu J; Ke XY; Wang HQ; Shen ZX; Yu SY; Liu T; Shi XL Ai Zheng; 2005 Dec; 24(12):1421-6. PubMed ID: 16351785 [TBL] [Abstract][Full Text] [Related]
10. Standard treatment of advanced-stage diffuse large B-cell lymphoma. Coiffier B Semin Hematol; 2006 Oct; 43(4):213-20. PubMed ID: 17027655 [TBL] [Abstract][Full Text] [Related]
11. Dose-dense R-CHOP-14 supported by pegfilgrastim in patients with diffuse large B-cell lymphoma: a phase II study of feasibility and toxicity. Brusamolino E; Rusconi C; Montalbetti L; Gargantini L; Uziel L; Pinotti G; Fava S; Rigacci L; Pagnucco G; Pascutto C; Morra E; Lazzarino M Haematologica; 2006 Apr; 91(4):496-502. PubMed ID: 16537117 [TBL] [Abstract][Full Text] [Related]
12. Improved therapeutic outcomes of DLBCL after introduction of rituximab in Korean patients. Park YH; Lee JJ; Ryu MH; Kim SY; Kim DH; Do YR; Lee KH; Oh SJ; Kim YK; Suh CW; Heo DS; Ryoo BY; Kim JK; Song HS; Lee WS; Kim HJ; Bang YJ; Yang SH; Sohn SK; Kang YK; Ann Hematol; 2006 Apr; 85(4):257-62. PubMed ID: 16416337 [TBL] [Abstract][Full Text] [Related]
13. Dose-intensified treatment of advanced-stage diffuse large B-cell lymphomas. Held G; Schubert J; Reiser M; Pfreundschuh M; Semin Hematol; 2006 Oct; 43(4):221-9. PubMed ID: 17027656 [TBL] [Abstract][Full Text] [Related]
15. Higher fungal infection rate in elderly patients (more than 80 years old) suffering from diffuse large B cell lymphoma and treated with rituximab plus CHOP. Lin PC; Hsiao LT; Poh SB; Wang WS; Yen CC; Chao TC; Liu JH; Chiou TJ; Chen PM Ann Hematol; 2007 Feb; 86(2):95-100. PubMed ID: 17031689 [TBL] [Abstract][Full Text] [Related]
16. [A case of pulmonary intravascular lymphoma treated with CHOP chemotherapy plus rituximab]. Ohkubo H; Yoshida T; Ohta K; Takaku T; Katagiri T; Paku J; Kasuga I; Minemura K; Gotoh A; Serizawa H; Mukai K; Ohyashiki K Gan To Kagaku Ryoho; 2005 Apr; 32(4):553-6. PubMed ID: 15853227 [TBL] [Abstract][Full Text] [Related]
17. Combined treatment with rituximab and anthracycline-containing chemotherapy for primary cutaneous large B-cell lymphomas, leg type, in elderly patients. Guyot A; Ortonne N; Valeyrie-Allanore L; Bagot M Arch Dermatol; 2010 Jan; 146(1):89-91. PubMed ID: 20083704 [No Abstract] [Full Text] [Related]
18. R-CHOP-14 in patients with diffuse large B-cell lymphoma younger than 70 years: a multicentre, prospective study. Rueda A; Sabin P; Rifá J; Llanos M; Gómez-Codina J; Lobo F; García R; Herrero J; Provencio M; Jara C; Hematol Oncol; 2008 Mar; 26(1):27-32. PubMed ID: 17868190 [TBL] [Abstract][Full Text] [Related]
19. Diffuse large B-cell lymphoma. Ng AK Semin Radiat Oncol; 2007 Jul; 17(3):169-75. PubMed ID: 17591563 [TBL] [Abstract][Full Text] [Related]
20. Interaction between BCL2 and interleukin-10 gene polymorphisms alter outcomes of diffuse large B-cell lymphoma following rituximab plus CHOP chemotherapy. Park YH; Sohn SK; Kim JG; Lee MH; Song HS; Kim MK; Jung JS; Lee JJ; Kim HJ; Kim DH Clin Cancer Res; 2009 Mar; 15(6):2107-15. PubMed ID: 19276283 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]